Medtronic Gains ICD Market Share Despite Slowed Growth; DES Planned In ’07
This article was originally published in The Gray Sheet
Executive Summary
Though implantable cardioverter defibrillator market growth has slowed in the U.S., Medtronic expanded its share of the market during its most recent fiscal quarter - likely at the expense of St. Jude
You may also be interested in...
Guidant’s Problems Go Beyond Bad Communication – Boston Scientific CEO
Boston Scientific will overhaul product design at recently acquired Guidant to prevent the recurrence of malfunctioning pacemakers and implantable defibrillators
Guidant’s Problems Go Beyond Bad Communication – Boston Scientific CEO
Boston Scientific will overhaul product design at recently acquired Guidant to prevent the recurrence of malfunctioning pacemakers and implantable defibrillators
Cardiology Firms Vet CMS’ Proposed Revamp Of Hospital Inpatient Payments
Three cardiac device heavyweights expressed support for the end goals of CMS' proposed revisions to the hospital inpatient payment system during quarterly earnings calls last week, but heartily disagreed with CMS' approach to achieving its objectives